Around 10% of pituitary tumors are estimated to be aggressive and associated with poor prognosis. Loss of heterozygosity (LOH) in chromosome 11q13 has been observed in aggressive pituitary tumors (APTs). Both MEN1 and AIP, located on 11q13 with an interval of 2.7 Mb, have been discovered as genetic markers of APTs. We...
Shi Chen, Jia-Qi Qiang, Lin Lu et al.· Health and Metabolism· 0 citations
Pituitary neuroendocrine tumors (PitNETs) present significant clinical challenges due to unpredictable invasive behavior and lack of reliable molecular predictors. While the extracellular matrix (ECM), particularly type IV collagen, has emerged as a critical mediator of tumor progression, its mechanistic role in PitNET...
Jie Liu, Zhi-Min Li, K. Deng et al.· Endocrine-Related Cancer· 0 citations
DPAs involving a corticotroph component should be considered as a possible explanation for persistent hypercortisolism after TSS when the resected lesion is negative for ACTH and T-PIT and the role of adjunctive molecular imaging remains preliminary.
Di Zhang, Wan Su, Jing-Hua Liu et al.· Endocrine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.